Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01203501 · ClinicalTrials.gov registry record

In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants

A clinical trial of Cerebral Palsy and Infant, Newborn, sponsored by NICHD Neonatal Research Network.

Completed
Registry status
1,339
Enrollment target
15
Study locations

NCT01203501 is a study of Cerebral Palsy and Infant, Newborn that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 1,339 participants, above the 215-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (523% higher). The trial reports 15 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01203501, a study of Cerebral Palsy and Infant, Newborn, has completed, sponsored by NICHD Neonatal Research Network.

COMPLETED
Registry status
1,339 participants
Enrollment target
15
Study locations

Study Summary

This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/infant conditions and magnesium exposure (including indications, timing and duration of exposure).

Conditions Studied

Cerebral Palsy Infant, Newborn Infant, Premature Infant, Small for Gestational Age Infant, Low Birth Weight Intracranial Hemorrhages Leukomalacia, Periventricular

Study Locations (15)

Ohio

  • Cincinnati Children's Medical Center - Cincinnati
  • Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland

Alabama

  • University of Alabama at Birmingham - Birmingham

California

  • Stanford University - Palo Alto

Connecticut

  • Yale University - New Haven

District of Columbia

  • George Washington University - Washington D.C.

Florida

  • University of Miami - Miami

Georgia

  • Emory University - Atlanta

Indiana

  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 1,339 participants
Start Date 1996-07
Est. Completion 2000-06

Sponsor

NICHD Neonatal Research Network

61 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01203501

The ClinicalTrials.gov registry entry for NCT01203501 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,339 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 215-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (523% higher). The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.

NCT01203501 reports 15 study locations spanning 14 distinct geographic areas - top geographies include Ohio, Alabama, California.

Frequently Asked Questions

What is clinical trial NCT01203501 about?

NCT01203501 is a clinical study titled "In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants". This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/in...

What is the current status of trial NCT01203501?

This trial is currently completed. The enrollment target is 1,339 participants. The study started on 1996-07. Estimated completion is 2000-06.

What conditions does trial NCT01203501 study?

This clinical trial studies the following conditions: Cerebral Palsy, Infant, Newborn, Infant, Premature, Infant, Small for Gestational Age, Infant, Low Birth Weight.

Who is sponsoring clinical trial NCT01203501?

This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01203501 being conducted?

This trial has 15 study locations across Alabama, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cerebral Palsy

All registered trials for this condition

Infant, Newborn

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.